Bridger Management, LLC (1)

Insider profile

Bridger Management, LLC (1)'s trades of Teva Pharmaceutical Industries Limited's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-18 2026-09-18 PrS Proposed sale
57,505
173.47
US$1,349,058
57,505 173.47 US$1,349,058
2025-12-12 2025-12-12 PrS Proposed sale
30,689
335.17
US$3,077,141
30,689 335.17 US$3,077,141
2025-11-26 2025-11-26 PrS Proposed sale
30,305
109.93
US$2,631,609
30,305 109.93 US$2,631,609
2025-11-06 2025-11-06 PrS Proposed sale
200,000
24.60
US$4,920,000
200,000 24.60 US$4,920,000
2025-09-12 2025-09-12 PrS Proposed sale
95,000
19.89
US$1,889,550
95,000 19.89 US$1,889,550
2024-12-20 2024-12-20 PrS Proposed sale
286,000
21.31
US$6,094,660
286,000 21.31 US$6,094,660
2024-06-18 2024-06-18 PrS Proposed sale
519,000
17.12
US$8,885,280
519,000 17.12 US$8,885,280